Applications are open to become the next President-elect for the Society, as well as opportunities to join Council as the Industry Trustee and Clinical Trustee. These roles, which are open for…
The meeting “Binding Kinetics and Mechanistic PK/PD Modelling in Early Drug Discovery” took place on 27-8 March 2023 at the Møller Institute in Cambridge, UK and it was a wonderful gathering for our…
If there’s one thing that people remember from biology at school, it’s that mitochondria are the powerhouses of the cell. They’re not wrong – in fact, every day the average healthy human produces…
As researchers, we often invest countless hours in conducting research and analysing data. However, when it comes to sharing our findings with non-scientific audiences, we may face challenges in…
The number of Food and Drug Administration (FDA) approvals per $1bn spent on drug development halved every 9 years between 1950 and 2010 (Scannell et al., 2012). ‘Eroom’s Law’ was the term chosen to…
It is an early Friday morning and no one, except security, is at the Advanced Research Centre at the University of Glasgow - just me and a few other student volunteers, who are diligently preparing…
Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional (two-headed) molecules that allow for highly selective targeted protein degradation (TPD). Contrary to traditional small molecule…
As part of my role as a pharmacology and physiology teaching assistant at the University of Aberdeen, I co-delivered two public engagement activities in March of this year. The first was a hybrid…
Running a research lab is a complex progress, but seeing the lab come to life is an amazing experience. In this issue of Pharmacology Matters, we are visiting the Mauro lab to learn about Professor…
In support of the 19th World Congress of Basic & Clinical Pharmacology (WCP2023), the International Union of Basic and Clinical Pharmacology Education Section (IUPHAR-Ed) developed an Education…
